Glenmark Shapes Immuno-Oncology Play With Early-Stage APC Asset

Glenmark Pharmaceuticals has in-licensed a small molecule oncology compound from APC Therapeutics Inc, expanding its interests in the promising immuno-oncology space. One of the founders of APC has even joined the Indian firm.